- Home
- WYY vs SRZN Comparison
WYY vs SRZN Comparison
Compare WYY & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- SRZN
- Stock Information
- Founded
- WYY 1991
- SRZN 2015
- Country
- WYY United States
- SRZN United States
- Employees
- WYY N/A
- SRZN 41
- Industry
- WYY EDP Services
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- WYY Technology
- SRZN Health Care
- Exchange
- WYY Nasdaq
- SRZN Nasdaq
- Market Cap
- WYY 35.6M
- SRZN 76.5M
- IPO Year
- WYY 1998
- SRZN N/A
- Fundamental
- Price
- WYY $2.87
- SRZN $9.75
- Analyst Decision
- WYY Strong Buy
- SRZN Strong Buy
- Analyst Count
- WYY 1
- SRZN 2
- Target Price
- WYY $7.00
- SRZN $38.50
- AVG Volume (30 Days)
- WYY 33.9K
- SRZN 18.1K
- Earning Date
- WYY 04-15-2025
- SRZN 05-07-2025
- Dividend Yield
- WYY N/A
- SRZN N/A
- EPS Growth
- WYY N/A
- SRZN N/A
- EPS
- WYY N/A
- SRZN N/A
- Revenue
- WYY $142,571,749.00
- SRZN $10,655,000.00
- Revenue This Year
- WYY $7.92
- SRZN N/A
- Revenue Next Year
- WYY $10.18
- SRZN N/A
- P/E Ratio
- WYY N/A
- SRZN N/A
- Revenue Growth
- WYY 34.47
- SRZN N/A
- 52 Week Low
- WYY $1.83
- SRZN $6.00
- 52 Week High
- WYY $6.25
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- WYY 39.25
- SRZN 43.14
- Support Level
- WYY $2.50
- SRZN $8.84
- Resistance Level
- WYY $3.25
- SRZN $10.40
- Average True Range (ATR)
- WYY 0.45
- SRZN 0.79
- MACD
- WYY -0.01
- SRZN -0.09
- Stochastic Oscillator
- WYY 51.52
- SRZN 22.26
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically the company generates a majority of its revenue from the United States and rest from Europe.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).